
LabCorp in discussions to acquire CRO PPD for over $8bn; terminated
Executive Summary
According to industry sources Laboratory Corp. of America Holdings (LabCorp) is in discussions to acquire contract research firm Pharmaceutical Product Development Inc. (PPD) for over $8bn including debt. (LabCorp is one of the parties bidding in an auction for PE-owned PPD.)
Deal Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Services
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com